2006
DOI: 10.1016/j.acra.2006.03.017
|View full text |Cite
|
Sign up to set email alerts
|

Radiation Safety With Use of I-125 Seeds for Localization of Nonpalpable Breast Lesions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
65
0
2

Year Published

2010
2010
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 70 publications
(69 citation statements)
references
References 6 publications
2
65
0
2
Order By: Relevance
“…The rate of positive margins in our study was 6%, which is at least comparable to the 8% rate reported by Gray et al (14)(15)(16)(17) and is well below the rate of 50,9% for excisions utilizing wire localization that was reported by Velanovic et al (29), both studies in non-palpable breast tumours. In a another prospective randomized trial of radioactive seed localization versus wire localization of non-palpable breast lesions, Hughes et al (30) found that radioactive seed localization resulted in a 35% relative improvement in the rate of negative margins in the first specimen and a 62% relative improvement in the rate of re-operation for positive margins.…”
Section: Lymph Node Statussupporting
confidence: 62%
See 1 more Smart Citation
“…The rate of positive margins in our study was 6%, which is at least comparable to the 8% rate reported by Gray et al (14)(15)(16)(17) and is well below the rate of 50,9% for excisions utilizing wire localization that was reported by Velanovic et al (29), both studies in non-palpable breast tumours. In a another prospective randomized trial of radioactive seed localization versus wire localization of non-palpable breast lesions, Hughes et al (30) found that radioactive seed localization resulted in a 35% relative improvement in the rate of negative margins in the first specimen and a 62% relative improvement in the rate of re-operation for positive margins.…”
Section: Lymph Node Statussupporting
confidence: 62%
“…(15)(16) The 125 Iodine ( 125 I) labelled titanium seed has been described for the localisation of non palpable breast tumours. (14)(15)(16)(17). We used the 125 I seed to mark the tumour bed in patients who were planned to receive neo-adjuvant chemotherapy for breast M A N U S C R I P T…”
Section: Introductionmentioning
confidence: 99%
“…The removed breast tissue requires special handling by the surgeon (Jakub et al, 2010) and pathologist (Graham et al, 2012). It also requires all of the involved personnel to pay careful attention to all of the radiation safety procedures and nuclear regulatory issues (Pavlicek et al, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…Due to 125Iodine radioemission, doubts arose regarding the doses absorbed by the patient and by the medical team. According to Pavlicek et al 23 , the maximum dose deposited in the residual breast that received the seed implant is rather low, around 2 cGy, equivalent to the dose of two X-ray incidences of a routine mammography. A survey on the amount of radiation received by the surgical team showed that no one received a dose higher than the environmental level 24 , proving the absence of risk to the medical staff, to the patient and to the general population.…”
Section: Introductionmentioning
confidence: 99%